Daratumumab and EPOCH for HIV+/‐ plasmablastic lymphoma: A feasibility study of the AIDS Malignancy Consortium (AMC 105) Meeting Abstract


Authors: Noy, A.; Barta, S. K.; Tan, C. R.; Kwon, D.; Baiocchi, R.; Rubinstein, P.; Ambinder, R.
Abstract Title: Daratumumab and EPOCH for HIV+/‐ plasmablastic lymphoma: A feasibility study of the AIDS Malignancy Consortium (AMC 105)
Meeting Title: 17th International Conference on Malignant Lymphoma (ICML)
Journal Title: Hematological Oncology
Volume: 41
Issue: Suppl. 2
Meeting Dates: 2023 Jun 13-17
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2023-06-01
Start Page: 710
Language: English
DOI: 10.1002/hon.3165_563
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 563 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ariela Noy
    351 Noy
  2. Carlyn Rose Tan
    130 Tan